Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A-375 | Vemurafenib | Defactinib | 0.000 | 0.000 | uM | 72 | hr | 3 | 22342 | 1082 | 1.0188 | 1.0000 | 0.0484 | 0.0468 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 0.000 | uM | 72 | hr | 1 | 9635 | 173 | 0.4953 | 0.4364 | 0.0180 | 0.0207 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 0.000 | uM | 72 | hr | 2 | 8079 | 212 | 0.4118 | 0.4364 | 0.0262 | 0.0207 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 0.000 | uM | 72 | hr | 3 | 7818 | 140 | 0.4019 | 0.4364 | 0.0179 | 0.0207 |
A-375 | Vemurafenib | Dasatinib | 0.000 | 0.000 | uM | 72 | hr | 2 | 20940 | 1098 | 1.0048 | 1.0000 | 0.0524 | 0.0504 |
COLO 858 | Vemurafenib | Defactinib | 0.100 | 0.000 | uM | 72 | hr | 3 | 4258 | 369 | 0.4617 | 0.4516 | 0.0867 | 0.0851 |
A-375 | Vemurafenib | Saracatinib | 1.000 | 0.000 | uM | 72 | hr | 3 | 3917 | 151 | 0.1971 | 0.1915 | 0.0385 | 0.0418 |
A-375 | Vemurafenib | Saracatinib | 3.160 | 0.000 | uM | 72 | hr | 3 | 2950 | 229 | 0.1424 | 0.1538 | 0.0776 | 0.0753 |
COLO 858 | Vemurafenib | Saracatinib | 0.100 | 0.000 | uM | 72 | hr | 3 | 2717 | 195 | 0.4272 | 0.4664 | 0.0718 | 0.0871 |
A-375 | Vemurafenib | Saracatinib | 1.000 | 0.000 | uM | 72 | hr | 2 | 3900 | 189 | 0.1943 | 0.1915 | 0.0485 | 0.0418 |
A-375 | Vemurafenib | Saracatinib | 1.000 | 0.000 | uM | 72 | hr | 1 | 3640 | 140 | 0.1832 | 0.1915 | 0.0385 | 0.0418 |
COLO 858 | Vemurafenib | Dasatinib | 0.000 | 0.000 | uM | 72 | hr | 2 | 8309 | 1285 | 1.0034 | 1.0000 | 0.1547 | 0.1514 |
COLO 858 | Vemurafenib | Defactinib | 0.100 | 0.000 | uM | 72 | hr | 2 | 4062 | 356 | 0.4400 | 0.4516 | 0.0876 | 0.0851 |
A-375 | Vemurafenib | Saracatinib | 0.316 | 0.000 | uM | 72 | hr | 1 | 4811 | 91 | 0.2471 | 0.2452 | 0.0189 | 0.0214 |
A-375 | Vemurafenib | Saracatinib | 0.316 | 0.000 | uM | 72 | hr | 2 | 4759 | 106 | 0.2436 | 0.2452 | 0.0223 | 0.0214 |
A-375 | Vemurafenib | Saracatinib | 0.316 | 0.000 | uM | 72 | hr | 3 | 4787 | 110 | 0.2448 | 0.2452 | 0.0230 | 0.0214 |
A-375 | Vemurafenib | JNK-IN-8 | 0.100 | 0.000 | uM | 72 | hr | 2 | 7416 | 121 | 0.4589 | 0.4477 | 0.0163 | 0.0178 |
COLO 858 | Vemurafenib | Defactinib | 0.100 | 0.000 | uM | 72 | hr | 1 | 4152 | 336 | 0.4531 | 0.4516 | 0.0809 | 0.0851 |
A-375 | Vemurafenib | JNK-IN-8 | 0.100 | 0.000 | uM | 72 | hr | 3 | 7190 | 141 | 0.4434 | 0.4477 | 0.0196 | 0.0178 |
COLO 858 | Vemurafenib | Saracatinib | 3.160 | 0.000 | uM | 72 | hr | 1 | 1155 | 902 | 0.0429 | 0.0307 | 0.7810 | 0.8523 |
COLO 858 | Vemurafenib | Defactinib | 0.316 | 0.000 | uM | 72 | hr | 3 | 3134 | 506 | 0.3120 | 0.2820 | 0.1615 | 0.1635 |
COLO 858 | Vemurafenib | Defactinib | 1.000 | 0.000 | uM | 72 | hr | 3 | 2252 | 1200 | 0.1249 | 0.1167 | 0.5329 | 0.5321 |
WM-115 | Vemurafenib | Dasatinib | 0.100 | 0.000 | uM | 72 | hr | 1 | 3738 | 249 | 0.8709 | 0.8638 | 0.0666 | 0.0643 |
MMAC-SF | Vemurafenib | PF562271 | 0.100 | 0.000 | uM | 72 | hr | 2 | 894 | 41 | 0.8637 | 0.8032 | 0.0459 | 0.0480 |
MMAC-SF | Vemurafenib | PF562271 | 0.100 | 0.000 | uM | 72 | hr | 1 | 736 | 41 | 0.7037 | 0.8032 | 0.0557 | 0.0480 |